However, we did observe a modest increase in the frequency of CD4+ T cells expressing Eomes between baseline and week 2 (which corresponds to IRIS onset) in TB-IRIS patients (medians: 4.48% vs 7.6%, respectively; P = .03). The gene discussed is CD4; the disease is tuberculosis.